drugset

drugset / Trial / NCT00996788

Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis

NCT00996788 ↗

Phase 3 Completed 55 enrolled PT Otsuka Indonesia

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To study the anti free radical \& inflammatory effect and safety of Rebamipide in patients suffering of dyspepsia due to chronic gastritis.

Timeline

Start: 2007-10
Primary completion: 2012-01
Completion: 2012-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Rebamipide	Small molecule	100 mg	—

Indications